Get emergency contraception for as low as $0 with insurance →
Get emergency contraception for as low as $0 with insurance →
$100.00
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Personalized, prescription appetite and metabolic support—clinician-guided and pharmacy-compounded.
Compounded GLP-1 peptide injections contain semaglutide, a GLP-1 receptor agonist that supports weight loss and metabolic health by mimicking a naturally occurring hormone involved in appetite regulation and glucose control. GLP-1 activity helps reduce hunger, slow gastric emptying, and improve blood sugar regulation—supporting sustainable weight loss when combined with healthy lifestyle changes.
How It Works with ReMDi
After a comprehensive medical evaluation and lab review, a licensed provider may prescribe compounded GLP-1 therapy if clinically appropriate. The medication is prepared by an FDA-registered, state-licensed compounding pharmacy and shipped directly to your home for convenient once-weekly use, with ongoing clinical oversight from the ReMDi Care Team.
Formulations may be customized and may include:
Treatment Details
What’s Included
Important Information
ReMDi Health offers a compounded formulation prepared with semaglutide base, not semaglutide salts. Partner pharmacies rigorously vet ingredients and perform third-party testing to ensure sterility, potency, and quality.
ReMDi Health operates independently and is not affiliated with Novo Nordisk, the manufacturer of Ozempic® and Wegovy®. Ozempic® and Wegovy® are FDA-approved medications; Wegovy® is approved for weight management, while Ozempic® is approved for type 2 diabetes and may be prescribed off-label for weight loss.
*Compounded medications are not FDA-approved. The FDA does not evaluate compounded drugs for safety, effectiveness, or manufacturing standards. Compounded products may differ in appearance and packaging from commercially manufactured medications.
Personalized, prescription appetite and metabolic support—clinician-guided and pharmacy-compounded.
Compounded GLP-1 peptide injections contain semaglutide, a GLP-1 receptor agonist that supports weight loss and metabolic health by mimicking a naturally occurring hormone involved in appetite regulation and glucose control. GLP-1 activity helps reduce hunger, slow gastric emptying, and improve blood sugar regulation—supporting sustainable weight loss when combined with healthy lifestyle changes.
How It Works with ReMDi
After a comprehensive medical evaluation and lab review, a licensed provider may prescribe compounded GLP-1 therapy if clinically appropriate. The medication is prepared by an FDA-registered, state-licensed compounding pharmacy and shipped directly to your home for convenient once-weekly use, with ongoing clinical oversight from the ReMDi Care Team.
Formulations may be customized and may include:
Treatment Details
What’s Included
Important Information
ReMDi Health offers a compounded formulation prepared with semaglutide base, not semaglutide salts. Partner pharmacies rigorously vet ingredients and perform third-party testing to ensure sterility, potency, and quality.
ReMDi Health operates independently and is not affiliated with Novo Nordisk, the manufacturer of Ozempic® and Wegovy®. Ozempic® and Wegovy® are FDA-approved medications; Wegovy® is approved for weight management, while Ozempic® is approved for type 2 diabetes and may be prescribed off-label for weight loss.
*Compounded medications are not FDA-approved. The FDA does not evaluate compounded drugs for safety, effectiveness, or manufacturing standards. Compounded products may differ in appearance and packaging from commercially manufactured medications.
There are no reviews yet.
Sign up for emails to know the latest on ReMDi offerings, hand-picked women’s health news, and more.
Reviews
There are no reviews yet.